Tasmanian Premier Peter Gutwein encouraged all Tasmanians to get vaccinated against COVID-19 after he received his first jab of the AstraZeneca vaccine.
Mr Gutwein assured Tasmanians that the AstraZeneca vaccine was safe and effective, allaying any fears that some in the population might have over rare blood clot concerns.
"I've been meeting in National Cabinet every week receiving advice from the nation's top medical experts. Their advice is that it is safe and effective, and I would encourage people to have it," Mr Gutwein said.
"At this stage I would hope that the vast majority of Tasmanians would have at least had their first injections by the start of the year, depending on supply we will do that as soon as we can."
All Tasmanians in the 50 to 69 age group will be eligible to receive their vaccines from May 3, while Aboriginal Tasmanians aged 50 to 54 are now eligible for vaccines.
These groups, like the Premier, will receive the AstraZeneca vaccine and not the Pfizer.
Following national health advice regarding blood clots the AstraZeneca vaccine is now only to be given to the over-50 age group, whilst the Pfizer vaccine is for use by the under-50 age groups.
Vaccinations for those aged 50 and above were brought forward this month, which makes timely use of the Australian-produced AstraZeneca doses.
This cohort will be able to access vaccinations from May 3 in state and GP clinics.
While the Pfizer vaccine is preferred for under 50s, the AstraZeneca vaccine can still be used for individuals aged under 50 who have chosen to have that vaccine, and have made an informed decision where they understand the risks and benefits,.
Those aged under-50 and who fall into the 1 a and 1 b, including aged care workers, disability care workers and residents, critical and high risk workers, healthcare workers and people with underlying medical conditions, now been priority.
Mr Gutwein has said Tasmania will take on an extra load of 12,000 COVID-19 vaccines to speed up rollout for staff in the aged care and disability.